Acrysof Iq Singlepiece Iol W/Ultrasert Delivery System: medical device reports filed with FDA

150

device reports naming the brand

0% of all MAUDE reports · about 14 a year

0

reports, 12 months to August 2026

0 in the 12 months before

21.3%

classified as malfunction

81.5% across the product code

0%

classified as death, as reported

0 reports · not verified by FDA

Reports by month, five years

No report naming Acrysof Iq Singlepiece Iol W/Ultrasert Delivery System was received in the five years to August 2026; the latest was received in December 2017.

By year received

Event type and report source

Grey bar: all 8,704 reports carrying product code KYB. Event type is the filer's classification and is not verified by FDA.

Device problems coded

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code KYB

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.